Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,187 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06568562RecruitingPhase 2
XL092 for advanced prostate cancer after PSMA therapy
This trial tests a new oral drug, XL092, for men with metastatic castration-resistant prostate cancer that has progressed after PSMA-targeted radiation therapy (Lu-177 PSMA-617). It aims to see if the drug can slow down the cancer.
Salt Lake City, UtahAges 18 years+ - NCT06570447RecruitingPhase 2
Glofitamab and chidamide for relapsed or refractory DLBCL
This trial tests a combination of two drugs, glofitamab and chidamide, for people with diffuse large B-cell lymphoma (DLBCL) that has come back or not responded after at least two prior treatments. The goal is to see if this combination can help when other options have stopped working.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06576934Recruiting
Early TIPS for liver cirrhosis with ascites
This study tests whether placing a small tube (called a TIPS) early in the liver can help people with cirrhosis who have their first episode of moderate to severe belly fluid buildup. The goal is to see if this early procedure improves outcomes compared to standard care.
Freiburg im BreisgauAges 18–80 - NCT06572267RecruitingPhase 2
Meplazumab for coronary artery disease
This trial tests if meplazumab can help people with chronic coronary syndrome who have stable angina. It focuses on patients with certain fatty deposits around their heart arteries that show up on a special CT scan.
Xi'an, ShannxiAges 18 years+ - NCT06569680RecruitingPhase 2
Mosunetuzumab for untreated extranodal marginal zone lymphoma
This trial tests a new drug called mosunetuzumab for people with a type of slow-growing lymphoma (extranodal marginal zone lymphoma) that has not been treated before. The goal is to see if the drug helps shrink the lymphoma and control the disease.
Miami, FloridaAges 18 years+ - NCT06572826Recruiting
Cardiac rehab after cardiogenic shock recovery
This study looks at whether a cardiac rehab program (exercise and education) can help people recover after being treated for cardiogenic shock, a life-threatening condition where the heart suddenly can't pump enough blood.
MilanAges 18–110 - NCT06573411RecruitingPhase 4
Finerenone for primary membranous nephropathy
This trial tests if finerenone, a medicine that may protect the kidneys, can help people with primary membranous nephropathy (a kidney disease that causes protein in urine). It is for adults who are already taking a standard blood pressure medicine but still have protein in their urine.
Guangzhou, GuangdongAges 18 years+ - NCT06581900Recruiting
Vitamin B12 in kids with sickle cell disease
This study looks at how children with sickle cell disease process vitamin B12 when exposed to a gas painkiller called MEOPA. It may help doctors understand how to manage treatment better.
ReimsAges 2–18 - NCT06581965RecruitingPhase 4
Personalized blood clot prevention for hip or knee replacement
This trial compares a personalized approach to preventing blood clots after hip or knee replacement surgery with the standard one-size-fits-all method. The goal is to see if tailoring prevention to each patient works better and is safer.
Apeldoorn, GelderlandAges 18 years+ - NCT06581874Recruiting
Mental health care follow-up after emergency visit
This study is testing a new way of coordinating mental health care between the hospital and community providers. It aims to see if this collaborative approach helps people who need follow-up after an emergency visit or a referral through the Med@psy program.
Toulon, VarAges 18 years+ - NCT06582342Recruiting
Does a 3D model predict treatment response better than CT for pancreatic cancer?
This study tests whether a special 3D scan can better tell if treatment has shrunk the tumor in people with pancreatic cancer. It may help your doctors decide if surgery is a good option.
AlicanteAges 18 years+ - NCT06571110Recruiting
Acupuncture for opioid pain relief in fibromyalgia
This study tests whether getting real acupuncture helps people with fibromyalgia who are already taking daily opioid pain medicine, compared to fake acupuncture (sham). The goal is to see if acupuncture can improve pain and reduce the need for opioids.
Irvine, CaliforniaAges 18–80 - NCT06567990Recruiting
Type 2 diabetes and fatty liver: new tests for disease tracking
This study is looking for people with type 2 diabetes and fatty liver disease to find better ways to track how the disease progresses. They will use special tests (biomarkers) to see if the liver is getting worse over time.
DijonAges 40–80 - NCT06572618RecruitingPhase 2
Nemtabrutinib plus rituximab for first-line mantle cell lymphoma
This trial tests a new combination of two drugs, nemtabrutinib (a targeted pill) and rituximab (an antibody infusion), for people with mantle cell lymphoma (MCL) who haven't had prior treatment. The goal is to see how well these drugs work together to control the lymphoma.
Duarte, CaliforniaAges 18 years+ - NCT06571565Enrolling by invitationEarly Phase 1
Manual lymph drainage for fibromyalgia patients
This trial tests whether manual lymph drainage (a gentle massage technique that helps move fluid in the body) can help reduce pain and other symptoms in women with fibromyalgia. It may offer a new, drug-free option to feel better.
Adana, çukurovaAges 25 years+ - NCT06568419Recruiting
Online therapy for mental health and work
This trial tests an online program to help people on sick leave due to anxiety or depression return to work. You would receive therapy through a secure website while staying with your regular mental health care team.
Oslo, BærumAges 18–65 - NCT06569615Recruiting
Comparing shock wave, laser, and cold therapy for sacroiliitis pain
This trial compares three different treatments (shock wave therapy, laser therapy, and cold therapy) for people with sacroiliitis, a condition that causes pain in the lower back, buttocks, or hips. The goal is to see which treatment works best for reducing pain and improving movement.
Najran, Najran RegionAges 20–50 - NCT06574581RecruitingPhase 1/Phase 2
Adipose stem cells for connective tissue disease with lung scarring
This trial tests whether stem cells from fat tissue can help people with connective tissue diseases (like lupus or scleroderma) whose lung scarring has worsened despite standard treatments. It aims to slow or stop lung damage.
TaichungAges 20–80 - NCT06569706Recruiting
Mastectomy with nipple preservation using endoscopy
This study tests a less invasive mastectomy for people with breast cancer. The surgery uses a small camera (endoscope) to remove breast tissue while keeping the nipple, and reconstruction is done at the same time.
MontpellierAges 20–75 - NCT06567314RecruitingPhase 2
Study of Ivonescimab for advanced skin or prostate cancer
This study tests a new immunotherapy medicine, ivonescimab, in people with advanced skin cancer or advanced prostate cancer. It looks at how safe and effective the drug is.
Houston, TexasAges 18 years+ - NCT06571734RecruitingPhase 2
Zanzalintinib for advanced sarcomas
This trial tests a new targeted therapy pill (XL092, also called zanzalintinib) for people with certain advanced sarcomas that have not responded to other treatments. The goal is to see if the drug shrinks tumors or slows their growth.
Chicago, IllinoisAges 18 years+ - NCT06577870Recruiting
Soothing nature videos for hospital ICU patients
This study tests whether watching calming, immersive nature scenes (called sensory projections) can help patients feel more relaxed while in the hospital's intensive care unit. If you qualify, you'll be able to use these projections during your stay.
MassyAges 18 years+ - NCT06575101Recruiting
Energy Use in Cardiac Arrest Patients During Temperature Control
This study will measure how much energy your body burns and what fuels it uses (like fat or sugar) during temperature management after a cardiac arrest. It aims to learn how to better support your recovery.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06572735Recruiting
PARP Inhibitor Dosing in Older Ovarian Cancer Patients
This trial studies how well older adults (70+) with advanced ovarian cancer tolerate PARP inhibitors in real-world care. It aims to see if the standard dose works for this age group.
AmiensAges 70 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,187 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.